Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
Public ClinicalTrials.gov record NCT01812213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)
Study identification
- NCT ID
- NCT01812213
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Navidea Biopharmaceuticals
- Industry
- Enrollment
- 76 participants
Conditions and interventions
Conditions
Interventions
- [18F]NAV4694 Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2013
- Primary completion
- Nov 1, 2017
- Completion
- Nov 1, 2017
- Last update posted
- Aug 13, 2024
2013 – 2017
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| Galiz Research | Hialeah | Florida | 33016 | — |
| Mt. Sinai Wien Center for Alzheimer's Disease | Miami Beach | Florida | 33140 | — |
| Compass Research | Orlando | Florida | 32806 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| SIU School of Medicine | Springfield | Illinois | 62702 | — |
| McLean Hospital | Belmont | Massachusetts | 02478 | — |
| Qunicy Medical Center, Alzheimer's Disease Center | Quincy | Massachusetts | 02169 | — |
| Neurological Associates of Albany | Albany | New York | 12208 | — |
| Albert Einstein College of Medicine | The Bronx | New York | 10461 | — |
| Wake Forest School of Medicine | Winston-Salem | North Carolina | 21157 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01812213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2024 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01812213 live on ClinicalTrials.gov.